Complete Clinical, Histopathologic and Molecular Remission of Primary Myelofibrosis with Long-Term Treatment with the JAK1/2 Inhibitor Ruxolitinib
暂无分享,去创建一个
D. Niederwieser | U. Siebolts | H. Al-Ali | T. Lange | A. Monecke | K. Hubert | Claudia Wichenhauser | G. Prashanth